
Definium Therapeutics, Inc.
USD47.10
+0.55 (+1.18%)
CEO
Robert Barrow
IPO Date
2016-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$46.50
Prev. Close
$46.55
Day Low
$46.05
Day High
$49.20
52W Low
$12.88
52W High
$49.20
Market Cap
$5.14B
Volume
3.35M
| 23 Jun 2026 |
| Baird |
| Outperform |
| Outperform |
| maintain |
| 22 Jun 2026 | Leerink Partners | Outperform | Outperform | maintain |
| 22 Jun 2026 | Oppenheimer | Outperform | Outperform | maintain |
| 16 Jun 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 8 May 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 22 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |
| 16 Apr 2026 | Canaccord Genuity | Buy | Buy | maintain |